Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Study Identifier
191622-096
CT.gov Identifier
NCT00915525
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Bladder Disorder - Overactive Bladder
    • Study Drug
  • botulinum toxin Type A
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Participation in preceding study 191622-095 (NCT00910845) or 191622-520 (NCT00910520)
    Exclusion Criteria:
    * Females who are pregnant, nursing or planning a pregnancy * Patient has any condition or situation which, in the Investigators opinion, would put the patient at risk from continuing treatment with botulinum toxin Type A

    Protocol Summary

    The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable
    Location
    Ghent, Belgium
    Status
    Not applicable
    Location
    Victoria, British Columbia, Canada
    Status
    Not applicable
    Location
    Prague, Czech Republic
    Status
    Not applicable
    Location
    Tübingen, Germany
    Status
    Not applicable
    Location
    Warsaw, Poland
    Status
    Not applicable
    Showing {first} - {last} of {total} Results